ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 348977 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 348977; 2) Community: the network communities that were significantly associated with the response to NSC 348977; 3) Molecule: the relationships between components within communities and NSC 348977; 4) MDR: the compounds that were significantly associated with the NSC 348977.

NSC Compound Enrichment Correlation
NSC 747253 Trihexyl(tetradecyl)phosphonium Tetrafluoroborate 0.0406225271888776 0.20409571
NSC 749505 3,4-diphenylisoxazolo[3,4-d]pyridazin-7(6H)-one 0.0406225271888776 0.12398675
NSC 753203 N-(2-(4-(6-(4-fluorophenyl)imidazo[2,1-b]thiazol-5-yl)pyrimidin-2-ylamino)ethyl)-4-methoxybenzamide 0.0406225271888776 0.03421186
NSC 2626 Tenox PG 0.0407060322613561 -0.14212743
NSC 34475 Androst-5-en-16.beta.-ol, 3.beta.-methoxy- (8CI) 0.0407060322613561 -0.0065883821
NSC 34780 Null 0.0407060322613561 0.34825368
NSC 59620 (4a,6a,9-trimethyl-6,7-dioxo-2,3,4,4b,5,6b,10,10a,11,11a,11b,12,13,13a-tetradecahydro-1H-indeno[2,1-a]phenanthren-2-yl) acetate 0.0407060322613564 0.072371674
NSC 679434 Null 0.0407060322613564 0.40500075
NSC 703138 Null 0.0407060322613564 -0.1055723
NSC 709238 Hepta-2,4-dienamide, 7-[4-(dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl- 7-oxo-, (2E,4E,6R)- 0.0407060322613564 0.21520611
Total:38  Current:33    [First] [Prev] [Next] [Last]